Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6506)
All Articles published online
|
Publishing Process of This Article
|
Jan 7, 2014 (publication date) through Jan 7, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Lee JE, Bae SH, Choi JY, Yoon SK, You YK, Lee MA. Epirubicin, Cisplatin, 5-FU combination chemotherapy in sorafenib-refractory metastatic hepatocellular carcinoma. World J Gastroenterol 2014; 20(1): 235-241 [PMID: 24415877 DOI: 10.3748/wjg.v20.i1.235] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i1/235.htm |
| Number | Citing Articles |
| 1 |
Natalya P. Bgatova, Olga P. Makarova, Anastasiya A. Pozhidayeva, Yurii I. Borodin, Lubov N. Rachkovskaya, Vladimir I. Konenkov. Effects of Lithium Nano-Scaled Particles on Local and Systemic Structural and Functional Organism Transformations Under Tumour Growth. Achievements in the Life Sciences 2014; 8(2): 101 doi: 10.1016/j.als.2015.01.003
|
| 2 |
YONGKANG SHI, JUN MA, KE CHEN, BIN CHEN. Konjac glucomannan enhances 5-FU-induced cytotoxicity of hepatocellular carcinoma cells via TLR4/PERK/CHOP signaling to induce endoplasmic reticulum stress. Oncology Research 2022; 30(4): 201 doi: 10.32604/or.2022.027584
|
| 3 |
Jing-qiu Li, Xian Wu, Lu Gan, Xiang-liang Yang, Ze-hong Miao. Hypoxia induces universal but differential drug resistance and impairs anticancer mechanisms of 5-fluorouracil in hepatoma cells. Acta Pharmacologica Sinica 2017; 38(12): 1642 doi: 10.1038/aps.2017.79
|
| 4 |
Mariam Mroweh, Thomas Decaens, Patrice N Marche, Zuzana Macek Jilkova, Flora Clément. Modulating the Crosstalk between the Tumor and Its Microenvironment Using RNA Interference: A Treatment Strategy for Hepatocellular Carcinoma. International Journal of Molecular Sciences 2020; 21(15): 5250 doi: 10.3390/ijms21155250
|
| 5 |
Hyeon-Jong Kim, Seung Hyuk Lee, Hyun Jeong Shim, Hyun Jin Bang, Sang Hee Cho, Ik-Joo Chung, Eu Chang Hwang, Jun Eul Hwang, Woo Kyun Bae. Hepatic arterial infusion chemotherapy versus systemic therapy for advanced hepatocellular carcinoma: a systematic review and meta-analysis. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1265240
|
| 6 |
Paul B Tchounwou, Shaloam Dasari, Felicite K Noubissi, Paresh Ray, Sanjay Kumar. Advances in Our Understanding of the Molecular Mechanisms of Action of Cisplatin in Cancer Therapy. Journal of Experimental Pharmacology 2021; : 303 doi: 10.2147/JEP.S267383
|
| 7 |
2022 KLCA-NCC Korea Practice Guidelines for the Management of Hepatocellular Carcinoma. Korean Journal of Radiology 2022; 23(12): 1126 doi: 10.3348/kjr.2022.0822
|
| 8 |
Bahareh Farasati Far, Dorsa Rabie, Parisa Hemati, Parastoo Fooladpanjeh, Neda Faal Hamedanchi, Nima Broomand Lomer, Arian Karimi Rouzbahani, Mohammad Reza Naimi-Jamal. Unresectable Hepatocellular Carcinoma: A Review of New Advances with Focus on Targeted Therapy and Immunotherapy. Livers 2023; 3(1): 121 doi: 10.3390/livers3010011
|
| 9 |
Qing-Qiang Shi, Guo-Wei Zuo, Zi-Qiang Feng, Lv-Cui Zhao, Lian Luo, Zhi-Mei You, Dang-Yang Li, Jing Xia, Jing Li, Di-Long Chen. Effect of Trichostatin A on Anti HepG2 Liver Carcinoma Cells: Inhibition of HDAC Activity and Activation of Wnt/β-Catenin Signaling. Asian Pacific Journal of Cancer Prevention 2014; 15(18): 7849 doi: 10.7314/APJCP.2014.15.18.7849
|
| 10 |
Jianhong Yang, Heying Pei, Hong Luo, Afu Fu, Hansuo Yang, Jia Hu, Chengjian Zhao, LuLu Chai, Xiang Chen, Ximing Shao, Chunyu Wang, Wenshuang Wu, Li Wan, Haoyu Ye, Qiang Qiu, Aihua Peng, Yuquan Wei, Li Yang, Lijuan Chen. Non-toxic dose of liposomal honokiol suppresses metastasis of hepatocellular carcinoma through destabilizing EGFR and inhibiting the downstream pathways. Oncotarget 2017; 8(1): 915 doi: 10.18632/oncotarget.13687
|
| 11 |
2014 Korean Liver Cancer Study Group-National Cancer Center Korea Practice Guideline for the Management of Hepatocellular Carcinoma. Korean Journal of Radiology 2015; 16(3): 465 doi: 10.3348/kjr.2015.16.3.465
|
| 12 |
Omar Abdel-Rahman, Mona Fouad. Second line systemic therapy options for advanced hepatocellular carcinoma; a systematic review. Expert Review of Anticancer Therapy 2015; 15(2): 165 doi: 10.1586/14737140.2015.978295
|
| 13 |
Ru Wang, Hengwei Fan, Ming Sun, Zhongwei Lv, Wanwan Yi. Roles of BMI1 in the Initiation, Progression, and Treatment of Hepatocellular Carcinoma. Technology in Cancer Research & Treatment 2022; 21 doi: 10.1177/15330338211070689
|
| 14 |
Lin Liu, Ying-hui Zheng, Li Han, Shu-Kui Qin. Efficacy and safety of the oxaliplatin-based chemotherapy in the treatment of advanced primary hepatocellular carcinoma. Medicine 2016; 95(40): e4993 doi: 10.1097/MD.0000000000004993
|
| 15 |
2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma. Journal of Liver Cancer 2023; 23(1): 1 doi: 10.17998/jlc.2022.11.07
|
| 16 |
Dong Gui Hu, Shashikanth Marri, Ross A. McKinnon, Peter I. Mackenzie, Robyn Meech. Deregulation of the Genes that Are Involved in Drug Absorption, Distribution, Metabolism, and Excretion in Hepatocellular Carcinoma. The Journal of Pharmacology and Experimental Therapeutics 2019; 368(3): 363 doi: 10.1124/jpet.118.255018
|
| 17 |
Yao-Kuang Huang, Chieh-Ling Yen, Sz-Iuan Shiu, Shou-Wu Lee, Pi-Yi Chang, Hong-Zen Yeh, Teng-Yu Lee, William B. Coleman. Transcatheter arterial chemoembolization after stopping sorafenib therapy for advanced hepatocellular carcinoma. PLOS ONE 2017; 12(11): e0188999 doi: 10.1371/journal.pone.0188999
|
| 18 |
Hyung Joon Yim, Sang Jun Suh, Soon Ho Um. Current management of hepatocellular carcinoma: An Eastern perspective. World Journal of Gastroenterology 2015; 21(13): 3826-3842 doi: 10.3748/wjg.v21.i13.3826
|
| 19 |
KLCA Korean Liver Cancer Association, NCC National Cancer Center. 2018 Korean Liver Cancer Association–National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma. Gut and Liver 2019; 13(3): 227 doi: 10.5009/gnl19024
|
| 20 |
Minsi Li, Pengxuan Zhao, Ting Fan, Yan Chen, Xiaojuan Zhang, Chuanchuan He, Tan Yang, Robert J. Lee, Muhammad Waseem Khan, Shahid Masood Raza, Xiang Ma, Yao Lu, Guangya Xiang. Biocompatible co-loading vehicles for delivering both nanoplatin cores and siRNA to treat hepatocellular carcinoma. International Journal of Pharmaceutics 2019; 572: 118769 doi: 10.1016/j.ijpharm.2019.118769
|
| 21 |
Seawon Hwang, Jieun Lee, Jung Min Lee, Sook Hee Hong, Myung-Ah Lee, Hoo Geun Chun, Ho Jong Chun, Sung Hak Lee, Eun Sun Jung. Hepatocellular Carcinoma with Cervical Spine and Pelvic Bone Metastases Presenting as Unknown Primary Neoplasm. The Korean Journal of Gastroenterology 2015; 66(1): 50 doi: 10.4166/kjg.2015.66.1.50
|
| 22 |
2018 Korean Liver Cancer Association–National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma. Korean Journal of Radiology 2019; 20(7): 1042 doi: 10.3348/kjr.2019.0140
|
| 23 |
2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma. Clinical and Molecular Hepatology 2022; 28(4): 583 doi: 10.3350/cmh.2022.0294
|
| 24 |
Leilei Niu, Liping Liu, Shengli Yang, Jianwei Ren, Paul B.S. Lai, George G. Chen. New insights into sorafenib resistance in hepatocellular carcinoma: Responsible mechanisms and promising strategies. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2017; 1868(2): 564 doi: 10.1016/j.bbcan.2017.10.002
|